AMGN US Equity
Amgen IncHealth Care · Biological Products, (No Diagnostic Substances) · CIK 318154 · FY ends Dec 31$442.36
+17.08 (+4.02%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 13.3M |
| % of shares out | 2.5% |
| Days to cover | 5.2 |
| Δ vs 2026-07-15 | +3.4% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 13,280,607 | +3.4% | 2,575,575 | 5.2 |
| 2026-07-15 | 12,845,008 | -0.2% | 2,018,823 | 6.4 |
| 2026-06-30 | 12,870,865 | +5.5% | 3,271,795 | 3.9 |
| 2026-06-15 | 12,200,158 | +2.9% | 2,968,539 | 4.1 |
| 2026-05-29 | 11,852,360 | -3.6% | 2,380,675 | 5.0 |
| 2026-05-15 | 12,289,634 | -5.2% | 2,875,509 | 4.3 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
